Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

April 2012 - FRMC

Department
04/26/2012
Disease-modifying antirheumatic drugs for rheumatoid arthritis have been considered effective treatments that can reduce or prevent joint damage.
Disease-modifying antirheumatic drugs for rheumatoid arthritis have been considered effective treatments that can reduce or prevent joint damage.
Disease-modifying antirheumatic...
04/26/2012
First Report Managed Care
04/25/2012
Among women with epithelial ovarian cancer (EOC), patients having a germline mutation in BRCA1 or BRCA2 was associated with improved 5-year overall survival, with BRCA2 carriers having the best prognosis, according to study results published...
Among women with epithelial ovarian cancer (EOC), patients having a germline mutation in BRCA1 or BRCA2 was associated with improved 5-year overall survival, with BRCA2 carriers having the best prognosis, according to study results published...
Among women with epithelial...
04/25/2012
First Report Managed Care
04/25/2012
For 15 years, Minnesota has implemented programs to care for dual eligibles, people who are eligible for both Medicare and Medicaid.
For 15 years, Minnesota has implemented programs to care for dual eligibles, people who are eligible for both Medicare and Medicaid.
For 15 years, Minnesota has...
04/25/2012
First Report Managed Care
04/25/2012
Cases involving healthcare fraud, waste, and abuse have recently been gaining more widespread attention.
Cases involving healthcare fraud, waste, and abuse have recently been gaining more widespread attention.
Cases involving healthcare...
04/25/2012
First Report Managed Care
04/25/2012
Reston, Virginia—To cope with increasing Medicaid populations, the federal government and states are working together to emphasize quality initiatives and better understand how the Patient Protection and Affordable Care Act (ACA) will impact...
Reston, Virginia—To cope with increasing Medicaid populations, the federal government and states are working together to emphasize quality initiatives and better understand how the Patient Protection and Affordable Care Act (ACA) will impact...
Reston, Virginia—To cope with...
04/25/2012
First Report Managed Care
04/25/2012
State Medicaid officials discussed issues they face balancing difficult economic conditions and offered insights into how they will deal with potential problems. 
State Medicaid officials discussed issues they face balancing difficult economic conditions and offered insights into how they will deal with potential problems. 
State Medicaid officials...
04/25/2012
First Report Managed Care
04/25/2012
Chicago—After 4 years, patients with coronary heart disease who underwent coronary artery bypass grafting (CABG) had a significantly lower mortality rate compared with those who had percutaneous coronary intervention (PCI), according to a...
Chicago—After 4 years, patients with coronary heart disease who underwent coronary artery bypass grafting (CABG) had a significantly lower mortality rate compared with those who had percutaneous coronary intervention (PCI), according to a...
Chicago—After 4 years, patients...
04/25/2012
First Report Managed Care
04/25/2012
Chicago—An observational cohort study of a managed care database found that after 12 months of treatment, nearly half of high-risk patients discontinued using statins to lower lowdensity lipoprotein cholesterol (LDL-C), leading the authors to...
Chicago—An observational cohort study of a managed care database found that after 12 months of treatment, nearly half of high-risk patients discontinued using statins to lower lowdensity lipoprotein cholesterol (LDL-C), leading the authors to...
Chicago—An observational cohort...
04/25/2012
First Report Managed Care

News

News
04/25/2012
Results show that adding capecitabine or gemcitabine to anthracycline-taxane–based neoadjuvant chemotherapy did not improve pathologic complete response in women with breast cancer.
Results show that adding capecitabine or gemcitabine to anthracycline-taxane–based neoadjuvant chemotherapy did not improve pathologic complete response in women with breast cancer.
Results show that adding...
04/25/2012
First Report Managed Care

Department

Conference Insider
04/25/2012
Chicago—A genetic substudy of a phase 3 trial found that the benefit of ticagrelor compared with clopidogrel in patients with acute coronary syndrome (ACS) was not based on the presence of poor metabolizers of clopidogrel in the overall...
Chicago—A genetic substudy of a phase 3 trial found that the benefit of ticagrelor compared with clopidogrel in patients with acute coronary syndrome (ACS) was not based on the presence of poor metabolizers of clopidogrel in the overall...
Chicago—A genetic substudy of a...
04/25/2012
First Report Managed Care

Advertisement

Advertisement

Advertisement